Hagens Berman says it is investigating Regeneron melanoma trial disclosures

Legal Atlas Watchline · August 18, 2026

What happened

Key facts A PR Newswire release dated Aug. 18, 2026 was issued by Hagens Berman Sobol Shapiro LLP

Why it matters

Key facts The release concerns Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)

The details

Key facts A securities class action lawsuit has been filed involving Regeneron

Read the full report

Atlas Watchline The firm said it is pursuing a securities class action over Regeneron Pharmaceuticals’ disclosures about a… Read on Atlas Watchline Read on Atlas Watchline